TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE
The Italian Trade Agency (ITA) hosted the eighth edition of 'Italy on the Move' during the 43rd J.P. Morgan Healthcare Conference 2025, attracting over 230 executives and investors. The event highlighted investment opportunities in Italy's €270 Billion life sciences sector. Director General Mauro Battocchi presented Italy's achievements, including €2 billion in pharma R&D investments in 2023 and an average life expectancy of 83.8 years.
The event featured a panel discussion titled 'Navigating Transatlantic Partnerships in Life Sciences,' moderated by Audrey Greenberg, with participation from prominent executives including leaders from Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, Genenta Science, ENEA Tech and Biomedical, and DOC Pharma. Five Italian startups also pitched their innovations: Aavantgarde, Butterfly Decisions, Cellply, Medlea, and Sibylla Biotech.
L'Agenzia Italiana per il Commercio (ITA) ha ospitato l'ottava edizione di 'Italy on the Move' durante la 43esima Conferenza Sanitaria J.P. Morgan 2025, attirando oltre 230 dirigenti e investitori. L'evento ha messo in evidenza le opportunità di investimento nel settore delle scienze della vita in Italia, che vale 270 miliardi di euro. Il Direttore Generale Mauro Battocchi ha presentato i successi dell'Italia, compresi 2 miliardi di euro in investimenti R&D nel settore farmaceutico nel 2023 e un'aspettativa di vita media di 83,8 anni.
L'evento ha incluso una tavola rotonda intitolata 'Navigare nelle Partnership Transatlantiche nelle Scienze della Vita', moderata da Audrey Greenberg, con la partecipazione di importanti dirigenti tra cui leader di Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, Genenta Science, ENEA Tech e Biomedical, e DOC Pharma. Cinque startup italiane hanno presentato le loro innovazioni: Aavantgarde, Butterfly Decisions, Cellply, Medlea e Sibylla Biotech.
La Agencia Italiana de Comercio (ITA) organizó la octava edición de 'Italia en Movimiento' durante la 43ª Conferencia de Salud J.P. Morgan 2025, atrayendo a más de 230 ejecutivos e inversores. El evento destacó las oportunidades de inversión en el sector de 270 mil millones de euros de ciencias de la vida en Italia. El Director General Mauro Battocchi presentó los logros de Italia, incluyendo 2 mil millones de euros en inversiones en I+D farmacéutica en 2023 y una esperanza de vida media de 83,8 años.
El evento incluyó un panel de discusión titulado 'Navegando Asociaciones Transatlánticas en Ciencias de la Vida', moderado por Audrey Greenberg, con la participación de destacados ejecutivos, incluyendo líderes de Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, Genenta Science, ENEA Tech y Biomedical, y DOC Pharma. Cinco startups italianas también presentaron sus innovaciones: Aavantgarde, Butterfly Decisions, Cellply, Medlea y Sibylla Biotech.
이탈리아 무역청(ITA)은 2025년 제43회 JP 모건 헬스케어 컨퍼런스 기간 동안 '이탈리아의 이동' 제8회를 개최하여 230명 이상의 경영진 및 투자자를 유치했습니다. 이 행사에서는 이탈리아의 2,700억 유로의 생명 과학 분야에 대한 투자 기회를 강조했습니다. 마우로 바토키 총장은 이탈리아의 성과를 소개했으며, 2023년에는 20억 유로의 제약 연구개발 투자와 평균 기대 수명이 83.8세임을 언급했습니다.
이 행사에서는 오드리 그린버그가 주재하는 '생명 과학의 대서양 파트너십 탐색'이라는 제목의 패널 토론이 있었습니다. 여기에는 루베도 생명 과학, 브라코 이미징, 메나리니 그룹, TPG 캐피탈, 제넨타 과학, ENEA 테크 및 생물 의학, DOC 파마 등의 주요 경영진이 참여했습니다. 다섯 개의 이탈리아 신생 기업도 그들의 혁신을 발표했습니다: Aavantgarde, Butterfly Decisions, Cellply, Medlea 및 Sibylla Biotech.
L'Agence Italienne du Commerce (ITA) a accueilli la huitième édition de 'L'Italie en Mouvement' lors de la 43e Conférence de Santé J.P. Morgan 2025, attirant plus de 230 dirigeants et investisseurs. L'événement a mis en avant les opportunités d'investissement dans le secteur des 270 milliards d'euros de sciences de la vie en Italie. Le Directeur Général Mauro Battocchi a présenté les succès de l'Italie, y compris 2 milliards d'euros en investissements R&D pharmaceutiques en 2023 et une espérance de vie moyenne de 83,8 ans.
L'événement a également présenté une table ronde intitulée 'Naviguer dans les Partenariats Transatlantiques en Sciences de la Vie', modérée par Audrey Greenberg, avec la participation de dirigeants de Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, Genenta Science, ENEA Tech et Biomedical, et DOC Pharma. Cinq startups italiennes ont également présenté leurs innovations : Aavantgarde, Butterfly Decisions, Cellply, Medlea et Sibylla Biotech.
Die Italienische Handelsagentur (ITA) veranstaltete die achte Auflage von 'Italien im Gespräch' während der 43. J.P. Morgan Healthcare Conference 2025 und zog über 230 Führungskräfte und Investoren an. Die Veranstaltung hob die Investitionsmöglichkeiten im italienischen 270-Milliarden-Euro-Lebenswissenschaftssektor hervor. Generaldirektor Mauro Battocchi präsentierte die Errungenschaften Italiens, einschließlich 2 Milliarden Euro in Pharma-F&E-Investitionen im Jahr 2023 und einer durchschnittlichen Lebenserwartung von 83,8 Jahren.
Die Veranstaltung umfasste eine Podiumsdiskussion mit dem Titel 'Navigieren in transatlantischen Partnerschaften im Bereich Lebenswissenschaften', moderiert von Audrey Greenberg, mit der Teilnahme prominenter Führungskräfte wie den Leitern von Rubedo Life Sciences, Bracco Imaging, Menarini Group, TPG Capital, Genenta Science, ENEA Tech und Biomedical sowie DOC Pharma. Fünf italienische Startups präsentierten ebenfalls ihre Innovationen: Aavantgarde, Butterfly Decisions, Cellply, Medlea und Sibylla Biotech.
- Italy's life sciences sector valued at €270 Billion
- €2 billion invested in pharma R&D in 2023
- None.
- Over 230 Italian and
U.S. executives, Italian government leaders, and investors attended the eighth edition of "Italy On the Move" - Seven life sciences executives provided business insights during "Navigating Transatlantic Partnerships in Life Sciences" panel discussion and five Italian startups pitched their unique breakthroughs and investment opportunities
- Director General for the Promotion of Italy Mauro Battocchi discussed private and public/institutional financial opportunities in the
€270 Billion Italian life sciences sector1
As presented by Mauro Battocchi, Director General for the Promotion of
The following leaders shared their unique perspectives on investing in
- Frederick Beddingfield - CEO, Rubedo Life Sciences
- Fulvio Renoldi Bracco - Vice Chairman and CEO, Bracco Imaging
- Elcin Barker Ergun - CEO and Member of the Board, Menarini Group
- Karthic Jayaraman - Partner and Co-Head of Global Healthcare, TPG Capital
- Pierluigi Paracchi - CEO, Co-Founder and Chairman, Genenta Science (Nasdaq: GNTA)
- Maria Cristina Porta - General Director, ENEA Tech and Biomedical
- Riccardo Zagaria - CEO, DOC Pharma
To learn more about the five Italian startups featured in the program, visit their respective websites included below.
Trade Commissioner Giosafat Riganò expressed his enthusiasm for the success of
Contact for Future Events and Collaborations:
Italian Trade Agency –
losangeles@ice.it
About the Italian Trade Agency
The Italian Trade Agency is the government agency which promotes the globalization of Italian firms under the aegis of the Ministry of Foreign Affairs. ITA helps to develop, facilitate and promote Italian economic and trade relations with foreign countries, focusing on the needs of SMEs, their associations and partnerships. ITA sustains Italian firms in their internationalization process, promoting the marketing of Italian goods and services as well as the image of "Made in Italy" products around the world, while facilitating outward Italian investments and encouraging FDI attraction into Italy. ITA's headquarters are based in Rome, and it works through a large network of offices around the world which are acknowledged as "Trade Promotion Offices" of the Embassies or Consulates of Italy. https://www.ice.it/en/
LinkedIn: https://www.linkedin.com/company/italosangeles/
Twitter: https://twitter.com/ITALosAngeles
Facebook: https://www.facebook.com/italosangeles
About INNOVIT
The Italian Innovation and Culture Hub INNOVIT is a strategic initiative of the Italian Government for the promotion of the Country System's innovation in the
Web: innovitsf.com
LinkedIn: innovitsf
1Assolombarda. (2024, July). La rilevanza della filiera Life Science in Lombardia https://www.assolombarda.it/centro-studi/la-rilevanza-della-filiera-life-science-in-lombardia-edizione-2024 Accessed 1 January 2024.
View original content to download multimedia:https://www.prnewswire.com/news-releases/top-italian-and-us-life-sciences-executives-and-italian-government-leaders-shared-business-success-stories-with-investors-at-italy-on-the-move-2025-side-event-during-jp-morgan-healthcare-conference-302361963.html
SOURCE Italian Trade Agency
FAQ
What was the total investment in Italian pharma R&D for 2023?
How large is Italy's life sciences sector in 2025?
How many attendees participated in Italy on the Move 2025?
Which companies participated in the Transatlantic Partnerships panel at Italy on the Move 2025?
